Legal status in Iceland

Per-substance legal status for Iceland, from sourced statutes where available. Legal information, not legal advice; drug laws change, so confirm with the destination’s embassy or drug authority before you travel.

88 confirmed substances0 not individually verifiedLast updated October 2, 2026

Confirmed legal status

1P-LSD

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "1P-LSD", with "1-propionyllysergid" in the Annað nafn column, and the row identifies it by the printed chemical name "N,N-diethyl-6-methyl-1-propanoyl-9,10-didehydroergoline-8-carboxamide". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Iceland lists the lysergamide family by individual name rather than by a generic clause: 1cP-LSD, 1D-LSD, 1V-LSD and 6-allyl-6-norLSD each carry their own row in column B.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Iceland, reglugerð nr. 233/2001 um ávana- og fíkniefni og önnur eftirlitsskyld efni, Fylgiskjal I and Fylgiskjal II with articles 1, 2, 3, 6, 7 and 10 · lög nr. 65/1974 um ávana- og fíkniefni, articles 2, 2 a, 3, 4, 5 and 6 · almenn hegningarlög nr. 19/1940, article 173 a · lög nr. 32/2001, article 1 · reglugerð nr. 879/2025 · reglugerð nr. 1036/2025 · reglugerð nr. 1277/2022, articles 3, 4, 5 and 7 · island.is · Updated October 2, 2026

1P-LSD in Iceland, full detail →

2-FDCK

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2-fluorodeschloroketamine", and the row identifies it by the printed chemical name "2-(2-fluorophenyl)-2-(methylamino)cyclohexan-1-one". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. This row is one of the newest in the list: 3. gr. of reglugerð nr. 879/2025 added it, at P II with an "x", in force 9 August 2025.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

2-FDCK in Iceland, full detail →

25I-NBOMe

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "25I-NBOMe", with "NBOMe-2C-I, Cimbi-5" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(4-iodo-2,5-dimethoxyphenyl)-N- [(2methoxyphenyl)methyl]ethanamine". Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

25I-NBOMe in Iceland, full detail →

2C-B

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2C-B", with "2,5-dimethoxy-4-bromophenethylamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(4-bromo-2,5-dimethoxyphenyl)ethanamine". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

2C-B in Iceland, full detail →

2C-E

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2C-E", with "2,5-dimethoxy-4-ethylphenethylamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(4-ethyl-2,5-dimethoxyphenyl)ethanamine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

2C-E in Iceland, full detail →

2C-I

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2C-I", with "2,5-dimethoxy-4-iodophenethylamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(4-iodo-2,5-dimethoxyphenyl)ethanamine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

2C-I in Iceland, full detail →

2C-T-7

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2C-T-7", with "2,5-dimethoxy-4-propylthiophenethylamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(2,5-dimethoxy-4-propylthio-phenyl)ethanamine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

2C-T-7 in Iceland, full detail →

3-MMC

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "3-methylmethcathinone", with "3-MMC" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(methylamino)-1-(3-methylphenyl)propan-1-one". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

3-MMC in Iceland, full detail →

4-AcO-DMT

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "4-AcO-DMT", and the row identifies it by the printed chemical name "4-acetoxy-N,N-dimethyltryptamine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. A second row is printed as "4-Acetoxy-DMT", carrying O-acetylpsilocin and Psilacetin in its Annað nafn column, on the same terms.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

4-AcO-DMT in Iceland, full detail →

4-HO-MET

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "4-HO-MET", with "Metocin, Methylsybin, 4-hydroxy-N-methyl-nethyltryptamine" in the Annað nafn column, and the row identifies it by the printed chemical name "3-[2-[ethyl(methyl)amino]ethyl]-1H-indol-4-ol". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

4-HO-MET in Iceland, full detail →

5-MeO-DMT (Bufo / Toad)

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "5-MeO-DMT", with "5-methoxy-N,N-dimethyltryptamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(5-methoxy-1H-indol-3-yl)-N,N-dimethylethanamine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

5-MeO-DMT (Bufo / Toad) in Iceland, full detail →

6-APB

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "6-(2-aminopropyl)benzofuran", with "6-APB" in the Annað nafn column, and the row identifies it by the printed chemical name "1-(1-benzofuran-6-yl)propan-2-amine". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

6-APB in Iceland, full detail →

7-Hydroxymitragynine (7-OH)

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "7-hydroxymitragynine", with "Mitragynine hydroxyindolenine" in the Annað nafn column, and the row identifies it by the printed chemical name "methyl (E)-2-[3-ethyl-7a-hydroxy-8-methoxy- 1,2,3,4,6,7,7a,12b-octahydro-1H-indolo[2,3-a]quinolizin2-yl]-3-methoxyprop-2-enoate". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. The parent plant carries its own row as "Kratom", and mitragynine, of which this is the hydroxy metabolite, carries another.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

7-Hydroxymitragynine (7-OH) in Iceland, full detail →

Adderall

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. Adderall is a brand of mixed amphetamine salts and it is not named in Fylgiskjal I, which prints substances rather than products. What is printed is "Amphetamine", with "Amfetamín (íslenska)" in its Annað nafn column, and "Dextroamphetamine", with "Dexamphetamine" beside it, each at P II with an "x" in column B, and 6. gr. of the Act names Dexamfetamine as well. The salts are reached expressly rather than by inference, because 1. gr. of the reglugerð counts the salts of a listed substance as the substance. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Adderall in Iceland, full detail →

Alcohol

Legal status: Not a controlled substance in Iceland's narcotics list. Ethanol is not named in Fylgiskjal I, searched as alcohol, ethanol, etanol and áfengi, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. Alcohol in Iceland is governed by its own legislation and by the state retail monopoly rather than by the narcotics instruments, and that legislation was not read for this cell. Nothing in reglugerð nr. 233/2001 or in lög nr. 65/1974 reaches it, which is the only question these two instruments can answer.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Alcohol in Iceland, full detail →

Amanita muscaria

Legal status: Not a controlled substance in Iceland's narcotics list. Amanita muscaria is not named in Fylgiskjal I, and neither muscimol nor ibotenic acid is named there, nor are any of them named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. The contrast with the psilocybin mushrooms is the point. Iceland prints Psilocybin and Psilocin as separate rows at P I with an "x" in column B and names both in 6. gr. of the Act, and it reaches mescaline cacti by describing them, in the row "Kaktusar sem innihalda mescaline". It provides no comparable row, and no generic fungus clause, for the muscimol mushrooms. So the fly agaric sits outside the instrument while its psilocybin neighbours sit inside it.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Amanita muscaria in Iceland, full detail →

Amphetamine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Amphetamine", with "Amfetamín (íslenska)" in the Annað nafn column, and the row identifies it by the printed chemical name "1-phenylpropan-2-amine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Dexamfetamine", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Dextroamphetamine is printed on a row of its own at P II with an "x", so both the racemate and the dextro isomer are inside the prohibition.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Amphetamine in Iceland, full detail →

Amyl Nitrite

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Amyl nitrite", with "Allir isomerar" in the Annað nafn column, and the row identifies it by the printed chemical name "Pentyl nitrite". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. The row reaches every isomer on its own words, Allir isomerar, and Isobutyl nitrite carries a separate row on the same terms.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Amyl Nitrite in Iceland, full detail →

Ayahuasca

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. Ayahuasca is a preparation rather than a substance and it is not named in Fylgiskjal I, nor is Banisteriopsis caapi, nor are harmine and harmaline. What is printed is "Dimethyltryptamine", with "DMT" and "N,N-dimethyltryptamine" in its Annað nafn column, at P I with an "x" in column B, and 6. gr. of the Act names DMT as well. A brew containing DMT is therefore reached through that row, 1. gr. of the reglugerð counting solutions, extracts, concentrates, tinctures and preparations of a listed substance as the substance. The harmala alkaloids that make the brew orally active are a separate question and no row was found for them. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Ayahuasca in Iceland, full detail →

Barbiturates

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. The class name is not named in Fylgiskjal I: Iceland prints barbiturates by individual name, and barbituric acid itself has no row. What is printed carries different markers and, on one row, a different tier. Barbital and Phenobarbital are at P IV with an "x" in column B, Secobarbital at P II with an "x", Pentobarbital at P III with an "x", and Amobarbital at P III with column B blank, which puts that one barbiturate on the licensed medical route while its neighbours sit inside the 2. gr. prohibition. Six others, Allobarbital, Brallobarbital, Butobarbital, Cyclobarbital, Metohexital and Vinylbital, appear in 6. gr. of the Act or in the list or both, so the answer for any one barbiturate is a row question and not a class question. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Barbiturates in Iceland, full detail →

Benzodiazepines

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. The class name is not named in Fylgiskjal I: Iceland lists benzodiazepines one molecule at a time and prints no generic clause for the class. Fifty rows carry benzodiazepine in their printed or IUPAC names. Most of them carry an "x" in column B, among them Alprazolam, Bromazepam, Clonazepam, Lorazepam, Etizolam, Flunitrazepam, Nimetazepam, Nitrazepam, Oxazepam, Temazepam and Triazolam, but a minority do not, and Diazepam, Clorazepate, Estazolam and Ethyl loflazepate sit on the licensed medical route with column B blank. So the class splits across the two tiers and the answer for any given benzodiazepine has to be taken from its own row rather than from the class. The designer benzodiazepines are inside as well, Bromazolam, Clonazolam, Flualprazolam, Flubromazolam and Phenazepam among them, and reglugerð nr. 879/2025 entered P IV against that group. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Benzodiazepines in Iceland, full detail →

Buprenorphine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Buprenorphine", and the row identifies it by the printed chemical name "17-cyclopropylmethyl-4,5-epoxy-6,14-ethano-3-hydroxy- 6-methoxymorphinan-7-yl]-3,3-dimethylbutan-2-ol". Its Alþjóðasamningar column prints "P III", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Buprenorphine in Iceland, full detail →

Caffeine

Legal status: Not a controlled substance in Iceland's narcotics list. Caffeine is not named in Fylgiskjal I, searched as caffeine, coffein and koffín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. Nor is any other xanthine. Iceland's food and medicines legislation governs caffeine in drinks, supplements and tablets, and that legislation was not read for this cell. The narcotics instruments are silent on it, which is the whole of what they can say.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Caffeine in Iceland, full detail →

Cannabinol

Legal status: Not a controlled substance in Iceland on the face of the list. Cannabinol has no row: it is not named in Fylgiskjal I as cannabinol, as kannabinol or as CBN, and it is not named in the 6. gr. list of lög nr. 65/1974. Every hit for the string cannabinol in the list belongs to a different molecule: "Tetrahydrocannabinol", "Hexahydrocannabinol", "Dronabinol" and the delta isomer rows. That matters, because the Tetrahydrocannabinol row writes its own scope as THC and all of its isomers and derivatives. Cannabinol is the oxidation product of THC rather than an isomer of it, and whether that span or the derivative clause in 1. gr. carries it is not settled by anything printed in the instrument. This cell records the absence of a row and declines to decide the derivative question.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are printed here without being applied to this row: whether the offence reaches this row at all is exactly what was not established. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Cannabinol in Iceland, full detail →

Cannabis / THC

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Cannabis", with "Kannabis, Hass, Marijuana, Marihuana" in the Annað nafn column. The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Cannabis (Kannabis", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "N I+IV", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Cannabis-harpix, the resin, has its own row on identical terms, and Tetrahydrocannabinol is printed separately at P I with its scope written into the row as THC and all its isomers and derivatives including the acid.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Cannabis / THC in Iceland, full detail →

Cathinone

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Cathinone", with "Benzoylethanamine, Hagigat" in the Annað nafn column, and the row identifies it by the printed chemical name "2-amino-1-phenylpropan-1-one". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Cathinone", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Methcathinone is printed separately at P I with an "x", and 6. gr. of the Act names that one too.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Cathinone in Iceland, full detail →

CBD

Legal status: Not a controlled substance in Iceland in its own right, and the qualification is the whole answer. Cannabidiol has no row of its own: it is not named in Fylgiskjal I, searched across all 807 printed rows and both name columns as cannabidiol, kannabidiol and CBD, with no hit, and it is not named in the 6. gr. list of lög nr. 65/1974 either. What is printed nearby shows the drafter naming this family when it means to. "Tetrahydrocannabidiol", with "H4-CBD" beside it, is a row of its own with an "x" in column B, and "Tetrahydrocannabinol" is printed at P I with an "x" and with its scope written into the row as THC and all of its isomers and derivatives including the acid. So a CBD product carrying any THC is a preparation containing a listed substance under 1. gr. and lands inside the 2. gr. prohibition, while the isolated molecule has no place in the instrument at all. Which of those a given bottle is, is a question of analysis rather than of labelling.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

CBD in Iceland, full detail →

Clonazepam

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Clonazepam", and the row identifies it by the printed chemical name "5-(2-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4benzodiazepin-2-one". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Clonazepam in Iceland, full detail →

Cocaine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Cocaine", with "Benzoylmethylecgonine" in the Annað nafn column, and the row identifies it by the printed chemical name "Methyl 3-benzoyloxy-8-methyl-8azabicyclo[3.2.1]octane-4-carboxylate". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Cocainum", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "N I+III", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Cocaine in Iceland, full detail →

Codeine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Codeine", with "3-methylmorphine" in the Annað nafn column, and the row identifies it by the printed chemical name "7,8-didehydro-4,5-epoxy-3-methoxy-17methylmorphinan-6-ol". Its Alþjóðasamningar column prints "N II+III", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row is blank, and the blank is the answer: the 2. gr. prohibition reaches only a substance marked "x" in the "dálki B í fylgiskjali I", so this row sits outside it and on the licensed medical route instead. 3. gr. of lög nr. 65/1974 confines such a substance to use in Iceland "læknisfræðilegum og vísindalegum tilgangi", for medical and scientific purposes, and limits import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession to pharmacists, pharmaceutical wholesalers, manufacturers and holders of a specific Lyfjastofnun licence applied for on each occasion, while 1. mgr. 6. gr. of the reglugerð makes import, export, manufacture and wholesale of a marked substance conditional on a Lyfjastofnun licence. Its N II+III marker is the compound one the 1961 Convention uses for codeine preparations, and the blank column B is what leaves an ordinary codeine medicine on the pharmacy route rather than inside the 2. gr. prohibition.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is outside the 2. gr. prohibition and on the licensed medical route, so a prescribed medicine containing it is the ordinary case rather than an exception, and the traveller rule applies to it in full. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. This row is on the licensed medical route rather than inside the prohibition, so the ordinary dispensed packaging with its label and the prescription is what is asked for, and the quantity ceiling in 5. gr. is a condition of the permission rather than a guideline, which means the paperwork and the amount have to be right together. Nothing may be sent ahead by post or freight.

Codeine in Iceland, full detail →

Crack Cocaine

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. The word crack is not named in Fylgiskjal I, which prints chemical and pharmacopoeial names rather than preparations. Crack is cocaine in free-base form, and the free base is what the printed row "Cocaine" names, with "Benzoylmethylecgonine" in its Annað nafn column, at N I+III with an "x" in column B. The hydrochloride is reached as a salt of that row under 1. gr. so both forms arrive at the same placement and 6. gr. of the Act names Cocainum in addition. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Crack Cocaine in Iceland, full detail →

Delta-8-THC

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Δ8-THC", with "Δ8-tetrahydrocannabinol" in the Annað nafn column, and the row identifies it by the printed chemical name "6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6Hdibenzo[b,d]pyran-1-ol". Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Iceland also prints delta-8-THC-acetate and delta-8-THCP as rows of their own, each with an "x" and no treaty marker, the last two added by reglugerð nr. 879/2025.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Delta-8-THC in Iceland, full detail →

Diazepam

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Diazepam", and the row identifies it by the printed chemical name "7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4benzodiazepin-2-one". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row is blank, and the blank is the answer: the 2. gr. prohibition reaches only a substance marked "x" in the "dálki B í fylgiskjali I", so this row sits outside it and on the licensed medical route instead. 3. gr. of lög nr. 65/1974 confines such a substance to use in Iceland "læknisfræðilegum og vísindalegum tilgangi", for medical and scientific purposes, and limits import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession to pharmacists, pharmaceutical wholesalers, manufacturers and holders of a specific Lyfjastofnun licence applied for on each occasion, while 1. mgr. 6. gr. of the reglugerð makes import, export, manufacture and wholesale of a marked substance conditional on a Lyfjastofnun licence. Diazepam is one of the few benzodiazepines Iceland leaves out of column B: alprazolam, clonazepam, lorazepam and etizolam all carry an "x" and diazepam, clorazepate and estazolam do not, so the class does not move together.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is outside the 2. gr. prohibition and on the licensed medical route, so a prescribed medicine containing it is the ordinary case rather than an exception, and the traveller rule applies to it in full. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. This row is on the licensed medical route rather than inside the prohibition, so the ordinary dispensed packaging with its label and the prescription is what is asked for, and the quantity ceiling in 5. gr. is a condition of the permission rather than a guideline, which means the paperwork and the amount have to be right together. Nothing may be sent ahead by post or freight.

Diazepam in Iceland, full detail →

DMT

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Dimethyltryptamine", with "DMT, N,N-dimethyltryptamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(1H-indol-3-yl)-N,N-dimethylethanamine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "DMT", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

DMT in Iceland, full detail →

DOM

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "2,5-dimethoxy-4-methylamphetamine", with "DOM, STP" in the Annað nafn column, and the row identifies it by the printed chemical name "1-(2,5-dimethoxy-4-methylphenyl)propan-2-amine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "DOM", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

DOM in Iceland, full detail →

DXM

Legal status: Not printed in Iceland's narcotics list under its own name. Dextromethorphan is not named in Fylgiskjal I, searched as dextromethorphan and as dextrometorfan, and it is not named in the 6. gr. list of lög nr. 65/1974. Two close relatives are printed and both are instructive. "Levomethorphan", the levo isomer, and "Racemethorphan", the racemate that contains the dextro isomer, each carry a row at N I with column B blank. The 1961 Convention excludes dextromethorphan expressly; Iceland's list prints no exclusion beside either row, so it neither names the substance nor says it is out. Whether a dextromethorphan medicine is reached through the racemate row or through the isomer language in 1. gr. is not answered by anything printed here.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are printed here without being applied to this row: whether the offence reaches this row at all is exactly what was not established. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

DXM in Iceland, full detail →

Ephedrine

Legal status: Controlled in Iceland. Ephedrine has no row in Fylgiskjal I at all. It is printed in Fylgiskjal II, as "Ephedrine" with "Efedrín" beside it, at D I, which 1. gr. ties to list I of the 1988 United Nations Convention against Illicit Traffic. That places it as a precursor rather than as a narcotic: 1. mgr. 6. gr. makes import, export, manufacture and wholesale of a D I substance conditional on a Lyfjastofnun licence, 7. gr. requires a separate application for each consignment and record keeping on delivery, and 8. gr. forbids customs clearance without that licence. Pseudoephedrine is printed beside it on the same terms. The 2. gr. prohibition, which reaches only a substance marked "x" in column B of Fylgiskjal I, does not reach this row at all.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Ephedrine in Iceland, full detail →

Etizolam

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Etizolam", and the row identifies it by the printed chemical name "4-(2-chlorophenyl)-2-ethyl-9-methyl-6Hthieno[3,2f][1,2,4]triazolo[4,3-a][1,4]diazepine". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Etizolam carried no treaty marker until reglugerð nr. 879/2025 entered P IV against it, so its column B placement is older than its treaty one.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Etizolam in Iceland, full detail →

Fentanyl

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Fentanyl", with "Fentanil" in the Annað nafn column, and the row identifies it by the printed chemical name "N-phenyl-N-[1-(2-phenylethyl)piperidin-4yl]propanamide". Its Alþjóðasamningar column prints "N I", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row is blank, and the blank is the answer: the 2. gr. prohibition reaches only a substance marked "x" in the "dálki B í fylgiskjali I", so this row sits outside it and on the licensed medical route instead. 3. gr. of lög nr. 65/1974 confines such a substance to use in Iceland "læknisfræðilegum og vísindalegum tilgangi", for medical and scientific purposes, and limits import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession to pharmacists, pharmaceutical wholesalers, manufacturers and holders of a specific Lyfjastofnun licence applied for on each occasion, while 1. mgr. 6. gr. of the reglugerð makes import, export, manufacture and wholesale of a marked substance conditional on a Lyfjastofnun licence. Iceland's placement of fentanyl is not the one a reader expects. Morphine, oxycodone and methadone all carry an "x" while fentanyl does not, so the opioid the list treats least strictly on this axis is the most potent of them, and the difference is a drafting choice about the medical route rather than a judgement about harm.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is outside the 2. gr. prohibition and on the licensed medical route, so a prescribed medicine containing it is the ordinary case rather than an exception, and the traveller rule applies to it in full. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. This row is on the licensed medical route rather than inside the prohibition, so the ordinary dispensed packaging with its label and the prescription is what is asked for, and the quantity ceiling in 5. gr. is a condition of the permission rather than a guideline, which means the paperwork and the amount have to be right together. Nothing may be sent ahead by post or freight.

Fentanyl in Iceland, full detail →

Gabapentin

Legal status: Not a controlled substance in Iceland's narcotics list. Gabapentin is not named in Fylgiskjal I, searched as gabapentin and gabapentín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. Its close relative is printed and the difference is deliberate. "Pregabalin" carries a row in Fylgiskjal I, the only row in the whole list with neither a treaty marker nor an "x" in column B, which is to say Iceland took the trouble to bring pregabalin into the instrument and did not do the same for gabapentin. That is a listing decision rather than an omission, and it leaves gabapentin to the ordinary medicines legislation, which was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Gabapentin in Iceland, full detail →

GBL

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Gamma-Butyrolactone", with "GBL, 4-butyrolactone" in the Annað nafn column, and the row identifies it by the printed chemical name "oxolan-2-one". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Iceland treats the prodrug as a substance in its own right rather than leaving it to the derivative clause, and 1,4-butanediol carries a separate row on the same terms.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

GBL in Iceland, full detail →

GHB

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Gamma-hydroxybutyric acid", with "GHB, smjörsýra" in the Annað nafn column, and the row identifies it by the printed chemical name "4-hydroxybutanoic acid". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "GHB", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. A second row, "Gamma-hydroxybutyrate", carries the salt form into column B with no treaty marker, and reglugerð nr. 879/2025 moved the acid from P IV to P II, so an older reading of this row understates its treaty schedule.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

GHB in Iceland, full detail →

Heroin

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Heroin", with "Diacetylmorphine, Morphine diacetate, Diamorphine" in the Annað nafn column, and the row identifies it by the printed chemical name "3-acetoxy-7,8-didehydro-4,5-epoxy-17methylmorphinan-6-yl acetate". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Heroin", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "N I+IV", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Heroin in Iceland, full detail →

HHC

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Hexahydrocannabinol", with "HHC" in the Annað nafn column, and the row identifies it by the printed chemical name "6,6,9-trimethyl-3-pentyl-6a,7,8,9,10,10a-hexahydro-6H-benzo[c]chromen-1-ol". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Hexahydrocannabinol acetate is printed separately under HHC-O with an "x" and no treaty marker, and reglugerð nr. 879/2025 both corrected this row's IUPAC name and entered P II against it, so a reading taken before 9 August 2025 has the marker wrong.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

HHC in Iceland, full detail →

Hydrocodone

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Hydrocodone", and the row identifies it by the printed chemical name "4,5-epoxy-3-methoxy-17-methylmorphinan-6-one". Its Alþjóðasamningar column prints "N I", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row is blank, and the blank is the answer: the 2. gr. prohibition reaches only a substance marked "x" in the "dálki B í fylgiskjali I", so this row sits outside it and on the licensed medical route instead. 3. gr. of lög nr. 65/1974 confines such a substance to use in Iceland "læknisfræðilegum og vísindalegum tilgangi", for medical and scientific purposes, and limits import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession to pharmacists, pharmaceutical wholesalers, manufacturers and holders of a specific Lyfjastofnun licence applied for on each occasion, while 1. mgr. 6. gr. of the reglugerð makes import, export, manufacture and wholesale of a marked substance conditional on a Lyfjastofnun licence. Hydrocodone sits with fentanyl and codeine on the blank side of column B while morphine and oxycodone carry an "x", so the opioid rows do not move together and the column has to be read row by row.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is outside the 2. gr. prohibition and on the licensed medical route, so a prescribed medicine containing it is the ordinary case rather than an exception, and the traveller rule applies to it in full. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. This row is on the licensed medical route rather than inside the prohibition, so the ordinary dispensed packaging with its label and the prescription is what is asked for, and the quantity ceiling in 5. gr. is a condition of the permission rather than a guideline, which means the paperwork and the amount have to be right together. Nothing may be sent ahead by post or freight.

Hydrocodone in Iceland, full detail →

Ketamine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Ketamine", and the row identifies it by the printed chemical name "2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Iceland puts ketamine in column B with no treaty marker at all, which is a national decision rather than a convention one, and the medicine exception in 2. gr. is what leaves an authorised ketamine product lawful in clinical use.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Ketamine in Iceland, full detail →

Khat

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Khat", with "Catha edulis, Allir hlutar plöntunnar" in the Annað nafn column. The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Kat", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. The row carries the whole plant: its Annað nafn column adds Catha edulis and says Allir hlutar plöntunnar, all parts of the plant.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Khat in Iceland, full detail →

Kratom

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Kratom", with "Mitragyna speciosa" in the Annað nafn column. Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Iceland names the plant itself and both of its alkaloids: Mitragynine and 7-hydroxymitragynine each carry a row in column B with no treaty marker.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Kratom in Iceland, full detail →

Lorazepam

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Lorazepam", and the row identifies it by the printed chemical name "7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-2H- 1,4-benzodiazepin-2-one". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Lorazepam in Iceland, full detail →

LSA (Morning Glory)

Legal status: Not printed as a substance in Iceland's narcotics list. Lysergic acid amide has no row of its own: it is not named in Fylgiskjal I as LSA, as ergine or as lysergamide, and it is not named in the 6. gr. list of lög nr. 65/1974. The precursor carries a row of its own, which is a different thing. "Lysergic acid", with "Lýsergsýra" beside it, is printed in Fylgiskjal II at D I, the 1988 Convention list, which puts it on the licensing route in 6. gr. and 7. gr. rather than inside the 2. gr. prohibition. And 1. gr. of the reglugerð extends the definition of a controlled substance to the amides of anything in Fylgiskjal I or II. Lysergic acid amide is, on its name, an amide of a Fylgiskjal II substance, so whether it is reached by that clause and on what footing is a live question this cell cannot answer from the printed text.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are printed here without being applied to this row: whether the offence reaches this row at all is exactly what was not established. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

LSA (Morning Glory) in Iceland, full detail →

LSD

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Lysergic Acid Diethylamide", with "Lysergide, LSD, LSD-25" in the Annað nafn column, and the row identifies it by the printed chemical name "N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3fg]quinoline-9-carboxamide". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Lysergide", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

LSD in Iceland, full detail →

MDA

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Tenamphetamine", with "3,4-methylenedioxyamphetamine, MDA" in the Annað nafn column, and the row identifies it by the printed chemical name "1-(1,3-benzodioxol-5-yl)propan-2-amine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "MDA", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

MDA in Iceland, full detail →

MDMA

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "MDMA", and the row identifies it by the printed chemical name "1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "MDMA", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

MDMA in Iceland, full detail →

MDPV

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methylenedioxypyrovalerone", with "MDPV" in the Annað nafn column, and the row identifies it by the printed chemical name "1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

MDPV in Iceland, full detail →

Memantine

Legal status: Not a controlled substance in Iceland's narcotics list. Memantine is not named in Fylgiskjal I, searched as memantine and memantín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. Iceland does print other NMDA antagonists: Ketamine, Phencyclidine, Methoxetamine, 2-fluorodeschloroketamine and Diphenidine all carry rows, most of them with an "x" in column B. Memantine is not among them, and the list gives no generic clause for the pharmacological class, so the absence is a listing decision rather than an oversight the derivative language would repair. It is a prescription medicine and the ordinary medicines legislation governing it was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Memantine in Iceland, full detail →

Mephedrone (4-MMC)

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Mephedrone", with "4-methylmethcathinone, 4-MMC, 4methylphedrone" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(methylamino)-1-(4-methylphenyl)propan-1-one". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Mephedrone (4-MMC) in Iceland, full detail →

Mescaline

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Mescaline", with "3,4,5-trimethoxyphenethylamine" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(3,4,5-trimethoxyphenyl)ethanamine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Mescaline", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. A second row, "Kaktusar sem innihalda mescaline", carries the plants themselves into column B, naming cactus and seed of Ecinopsis pachanoi and Ecinopsis peruviana and, in its own words, others containing mescaline.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Mescaline in Iceland, full detail →

Methadone

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methadone", with "Dolophine, Amidone, Physeptone" in the Annað nafn column, and the row identifies it by the printed chemical name "6-dimethylamino-4,4-diphenylheptan-3-one". Its Alþjóðasamningar column prints "N I", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Methadone in Iceland, full detail →

Methamphetamine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methamphetamine", and the row identifies it by the printed chemical name "N-methyl-1-phenylpropan-2-amine". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Methamfetamine", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Methamphetamine in Iceland, full detail →

Methaqualone (Quaaludes)

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methaqualone", with "Metolquizolone" in the Annað nafn column, and the row identifies it by the printed chemical name "2-methyl-3-(2-methylphenyl)quinazolin-4-one". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Methaqualone", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Methaqualone (Quaaludes) in Iceland, full detail →

Methylone

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methylone", with "β-keto-3,4-methylendioxymethamphetamine, bk-MDMA" in the Annað nafn column, and the row identifies it by the printed chemical name "1-(1,3-benzodioxol-5-yl)-2-(methylamino)propan-1-one". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. A second row is printed under the alternative name bk-MDMA, also at P II with an "x".
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Methylone in Iceland, full detail →

Methylphenidate

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methylphenidate", with "Phenidylate" in the Annað nafn column, and the row identifies it by the printed chemical name "methyl 2-phenyl-2-(piperidin-2-yl)acetate". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Methylphenidate in Iceland, full detail →

Mitragynine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Mitragynine", and the row identifies it by the printed chemical name "Methyl (E)-2-(3-ethyl-8-methoxy-1,2,3,4,6,7,12,12bocta-hydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop2-enoate". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. The parent plant is listed too: "Kratom", with Mitragyna speciosa in its Annað nafn column, carries its own "x".
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Mitragynine in Iceland, full detail →

Modafinil

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Modafinil", and the row identifies it by the printed chemical name "2-[(diphenylmethyl)sulfinyl]acetamide". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Modafinil", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Modafinil is one of the few rows Iceland places in column B with no treaty marker while also naming it in 6. gr. of the Act, which is an unusually strict placement for a wakefulness medicine.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Modafinil in Iceland, full detail →

Morphine

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Morphine", and the row identifies it by the printed chemical name "7,8-didehydro- 4,5-epoxy-17-methylmorphinan-3,6-diol". Its Alþjóðasamningar column prints "N I", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Morphine in Iceland, full detail →

MXE

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Methoxetamine", with "MXE, 3-MeO-2-Oxo-PCE" in the Annað nafn column, and the row identifies it by the printed chemical name "2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. reglugerð nr. 879/2025 entered P II against this row, so its treaty marker is newer than its column B placement.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

MXE in Iceland, full detail →

Nicotine

Legal status: Not a controlled substance in Iceland's narcotics list. Nicotine is not named in Fylgiskjal I, searched as nicotine, nikotin and nikótín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. The three rows in which the string nicotin appears belong to opioids and not to nicotine: Nicocodine, Nicodicodine and Nicomorphine. Nicotine in Iceland is governed by the tobacco control legislation and by the rules on nicotine products, neither of which was read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Nicotine in Iceland, full detail →

Nimetazepam

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Nimetazepam", and the row identifies it by the printed chemical name "1,3-dihydro-1-methyl-7-nitro-5-phenyl-2H- 1,4benzodiazepin-2-one". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Nimetazepam in Iceland, full detail →

Nitrous Oxide

Legal status: Not a controlled substance in Iceland's narcotics list. Nitrous oxide is not named in Fylgiskjal I, searched as nitrous oxide, dinitrogen oxide, glaðloft and hláturgas, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. The only rows in which the string oxide appears at all belong to other molecules, Chlordiazepoxide, Codeine-N-oxide and Morphine-N-oxide. Iceland does reach some inhalants through Fylgiskjal II, where Toluene and Ethyl ether are printed at D II, but nitrous oxide is not there either. Its supply as a medical gas and its sale for catering use are governed by medicines and food law that was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Nitrous Oxide in Iceland, full detail →

Opium

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Opium", with "Þ.e. hverslags vara úr hrá-ópíum sem unnin er með ýmsum framleiðsluaðferðum, svo sem upplausn, suðu, ristun og gerjun í þeim tilgangi að umbreyta þykkni og gera það hæft til neyslu. Einnig leyfar sem verða eftir við reykingu á ópíum." in the Annað nafn column. Its Alþjóðasamningar column prints "N I+III", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Poppy straw is printed on a row of its own at N I with column B left blank, so the straw and its concentrate sit on the licensed medical route while prepared opium sits inside the prohibition, a split the reader has to keep.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Opium in Iceland, full detail →

Oxycodone

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Oxycodone", and the row identifies it by the printed chemical name "4,5-epoxy-14-hydroxy-3-methoxy-17-methylmorphinan6-one". Its Alþjóðasamningar column prints "N I", referring the row to the 1961 Single Convention on Narcotic Drugs, to whose schedules 1. gr. of the reglugerð ties every N marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Oxycodone in Iceland, full detail →

PCP

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Phencyclidine", and the row identifies it by the printed chemical name "1-(1-phenylcyclohexyl)piperidine". Its Alþjóðasamningar column prints "P II", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

PCP in Iceland, full detail →

Peyote

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. Peyote is not named in Fylgiskjal I, and neither Lophophora nor Lophophora williamsii appears anywhere in it. The row that reaches it names the class by description instead: "Kaktusar sem innihalda mescaline", cacti containing mescaline, whose Annað nafn column names cactus and seed of the species Ecinopsis pachanoi and Ecinopsis peruviana and, in its own words, others containing mescaline. Peyote contains mescaline, so it falls inside that description, and Mescaline itself is a separate printed row at P I with an "x" which 6. gr. of the Act also names. This is a placement read off a description rather than off a name, and it is labelled as such. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Peyote in Iceland, full detail →

Phenibut

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Phenibut", and the row identifies it by the printed chemical name "4-amino-3-phenylbutanoic acid". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Phenibut in Iceland, full detail →

Pink Cocaine / Tusi

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. Pink cocaine is a street name for a mixture rather than a molecule, and it is not named in Fylgiskjal I under that name or under tusi or tuci. What the name is usually sold as is printed: "2C-B", with "2,5-dimethoxy-4-bromophenethylamine" in its Annað nafn column, at P II with an "x" in column B, and "Ketamine", also with an "x" and no treaty marker. Cocaine itself, despite the street name, is a third printed row. Which of those a given sample contains is a question of analysis rather than of labelling, and all three sit inside the same prohibition, so the placement does not turn on the answer. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Pink Cocaine / Tusi in Iceland, full detail →

Poppers

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. Poppers is a street name for a group of alkyl nitrites and it is not named in Fylgiskjal I under that name. The nitrites themselves are printed: "Amyl nitrite", whose Annað nafn column reads Allir isomerar, all isomers, and "Isobutyl nitrite", each with an "x" in column B and no treaty marker. So a bottle sold as poppers is inside the prohibition if it contains either, and which nitrite it contains is a question of analysis rather than of labelling. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Poppers in Iceland, full detail →

Pregabalin

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Pregabalin", and the row identifies it by the printed chemical name "(3S)-3-(aminomethyl)-5-methylhexanoic acid". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Pregabalin is the only row in the whole of Fylgiskjal I that carries neither a treaty marker nor an "x" in column B, so it is there on the strength of the fifth limb of 1. gr. alone, the habit-forming medicines that may make a user dependent, and its copy-record status falls to be decided by Lyfjastofnun at marketing authorisation under 4. gr. rather than by any marker on the row.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is printed in Fylgiskjal I without a treaty marker and without an "x", so it reaches the traveller rule through the printing alone, which is all 5. gr. asks for. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. The row carries no marker, so nothing turns on a treaty schedule here, but it is printed in Fylgiskjal I and that is what brings it under 5. gr. quantity ceiling and post and freight prohibition alike. Carry it in its dispensed packaging with the prescription.

Pregabalin in Iceland, full detail →

Psilocybin

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Psilocybin", and the row identifies it by the printed chemical name "3-[2-(dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate". The Act names it as well: the 6. gr. list of lög nr. 65/1974, introduced by "Eftirtalin ávana- og fíkniefni falla undir 1. mgr. 2. gr.", prints "Psilocybinum", so this row is caught by the statutory prohibition in 1. mgr. 2. gr. of the Act and not by the regulation alone. Its Alþjóðasamningar column prints "P I", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. A medicine containing a substance carrying an N I to N IV or a P I to P III marker is "eftirritunarskyld", inside the copy-record regime for prescribing and dispensing set by 3. gr. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Psilocin is printed on its own row on the same terms, at P I with an "x" in column B, and 6. gr. of the Act names both, so a mushroom preparation reaches the same place through either molecule.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Psilocybin in Iceland, full detail →

Quetiapine

Legal status: Not a controlled substance in Iceland's narcotics list. Quetiapine is not named in Fylgiskjal I, searched as quetiapine and kvetíapín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. Iceland does bring some non-narcotic prescription medicines into the list where it judges there to be a dependence risk, Pregabalin and Carisoprodol among them, so the instrument is not confined to classical narcotics and the absence of quetiapine from it is a decision rather than a gap in scope. It is a prescription medicine and the ordinary medicines legislation governing it was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Quetiapine in Iceland, full detail →

Salvia divinorum

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Salvia divinorum". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Salvinorin A has a row of its own on the same terms, so both the plant and its active molecule sit in column B with no treaty marker.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Salvia divinorum in Iceland, full detail →

Scopolamine (Devil's Breath)

Legal status: Not a controlled substance in Iceland's narcotics list. Scopolamine is not named in Fylgiskjal I, searched as scopolamine, hyoscine and skópólamín, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. No tropane alkaloid of the nightshade family is printed anywhere in either Fylgiskjal. Cocaine, also a tropane, is there, but it is there as itself and the row carries nothing that would extend to atropine or hyoscine. Scopolamine is a licensed medicine in travel-sickness and anaesthetic use and the medicines legislation governing it was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Scopolamine (Devil's Breath) in Iceland, full detail →

Synthetic Cannabinoids (K2 / Spice)

Legal status: Controlled in Iceland, and the route to that answer is not the printed name of this row. The class name is not named in Fylgiskjal I: Iceland prints no generic clause for synthetic cannabinoids and lists them compound by compound. Individual compounds are printed in quantity, among them "JWH-018" with "AM-678" beside it and "AM-2201" at P II with an "x" in column B, and MDMB-4en-PINACA, 4F-MDMB-BINACA, 5F-MDMB-PICA and CUMYL-PeGACLONE, against each of which reglugerð nr. 879/2025 entered P II. The same reglugerð added ADB-5Br-INACA. Because the listing is name by name, a compound synthesised after the last amendment is reached only if it is a salt, ester, amide, peptide or derivative of a printed row, which is the one general clause Iceland does provide, and whether any particular new compound is such a derivative is a chemical question this cell does not answer. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Synthetic Cannabinoids (K2 / Spice) in Iceland, full detail →

THC-P

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Tetrahydrocannabiphorol", with "THCP" in the Annað nafn column, and the row identifies it by the printed chemical name "3-heptyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6Hbenzo[c]chromen-1-ol". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. delta-8-THCP is printed as a separate row on the same terms, added by reglugerð nr. 879/2025.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

THC-P in Iceland, full detail →

Tobacco

Legal status: Not a controlled substance in Iceland's narcotics list. Tobacco is not named in Fylgiskjal I, searched as tobacco, tóbak and Nicotiana, and it is not named in Fylgiskjal II or in the 6. gr. list of lög nr. 65/1974. The contrast with the other listed plants is worth holding. Iceland brings Cannabis, Khat with all parts of the plant, Kratom, Salvia divinorum, Poppy straw and cacti containing mescaline into the instrument by name or by description, so it does list plants when it means to, and it has not listed tobacco. Tobacco is governed by its own control legislation, which was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Tobacco in Iceland, full detail →

Tramadol

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Tramadol", and the row identifies it by the printed chemical name "2-[(dimethylamino)methyl]-1-(3methoxyphenyl)cyclohexan-1-ol". Its Alþjóðasamningar column is blank, so the row rests on the national listing alone rather than on a treaty schedule, and the copy-record duty in 3. gr. which attaches to the N I to N IV and P I to P III markers, is not engaged by any marker on this row. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons. Tramadol sits in column B with no treaty marker, which is stricter than the international position, and an authorised tramadol medicine stays lawful only through the marketing authorisation exception in 2. gr.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Tramadol in Iceland, full detail →

Xanax (Alprazolam)

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Alprazolam", and the row identifies it by the printed chemical name "8-chloro-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3a][1,4]benzodiazepine". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Xanax (Alprazolam) in Iceland, full detail →

Xylazine

Legal status: Not a controlled substance in Iceland's narcotics list. Xylazine is not named in Fylgiskjal I, searched as xylazine, xylazin and xýlasín across both name columns and the IUPAC column, and it is not named in Fylgiskjal II or in the 6. gr. list of log nr. 65/1974. Iceland has added nitazenes and fentanyl precursors in each of its last two amendments, reglugerð nr. 879/2025 moving 1-boc-4-AP, Norfentanyl and N-Phenyl-4-piperidinamine out of Fylgiskjal I and into Fylgiskjal II at D I, so the adulterant question is one the drafter has been working on. Xylazine is not among what it has reached. It is a veterinary sedative and the veterinary medicines legislation that governs it was not read for this cell.
Consequences if caught: The 2. gr. prohibition and the offence in 5. gr. of lög nr. 65/1974 both bite on a substance the instruments reach, and this row is not one of them. Iceland's published drug penalties are set out next so the reader can see what the narcotics regime does carry. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are Iceland's and not this substance's: this row is placed outside that regime, so they are recorded as Iceland's published drug penalties and not as this substance's exposure. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row is not printed in Fylgiskjal I, so 5. gr. of reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, which governs medicines containing a Fylgiskjal I substance, does not reach it, and the ordinary rule in 4. gr. applies instead. A traveller arriving from a state inside the European Economic Area may carry a year's supply for personal use at the directions of a doctor or of the marketing authorisation holder, and a traveller arriving from outside it is limited to 100 days. By post or freight the limit is 100 days from inside the European Economic Area, and sending from outside it is not permitted. Where the medicine is prescription only, 3. gr. still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival.
Documentation: No narcotics document is engaged by this row, because the narcotics instruments do not reach it. If it is a prescription medicine, 3. gr. of reglugerð nr. 1277/2022 still requires a doctor's certificate or the prescription with its directions, or the dispensing label, to be shown to customs on arrival, and the ordinary quantity ceilings in 4. gr. apply. The legislation outside the narcotics instruments that governs it was not read for this cell, so this is not advice that nothing else applies.

Xylazine in Iceland, full detail →

Zolpidem

Legal status: Controlled in Iceland. It is printed in Fylgiskjal I as "Zolpidem", and the row identifies it by the printed chemical name "N,N-dimethyl-2-[6-methyl-2-(4- methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide". Its Alþjóðasamningar column prints "P IV", referring the row to the 1971 Convention on Psychotropic Substances, to whose schedules 1. gr. of the reglugerð ties every P marker. That marker also carries a dispensing limit: 10. gr. lets a medicine in ATC groups N 05 B A and N 05 C carrying it be dispensed only in a quantity answering to "30 daga notkunar", thirty days' use at the defined daily dose. Column B of its row prints "x", and that mark is the operative one: 2. gr. of the reglugerð makes import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession of a substance marked "x" in the "dálki B í fylgiskjali I" "óheimil á íslensku forráðasvæði", unlawful on Icelandic territory. That prohibition is not absolute on its face. 2. gr. lifts it for a substance exempted under 3. mgr. 2. gr. of lög nr. 65/1974, for a medicine holding an Icelandic marketing authorisation from Lyfjastofnun, for a medicine otherwise permitted under the Medicines Act, and for a substance that may be imported, manufactured or wholesaled under 1. mgr. 6. gr. and Lyfjastofnun may exempt for scientific research or other special reasons.
Consequences if caught: The offence provisions reach this row through its placement, so they are set out here in full. The custodial ceiling for an offence against the Act and against the regulations made under it is imprisonment for up to 6 years, which 5. gr. of lög nr. 65/1974, the Narcotics Act, prints as "fangelsi allt að 6 árum", and the aggravated offence at article 173a of almenn hegningarlög nr. 19/1940, the General Penal Code, carries imprisonment for up to 12 years. Iceland prints no quantity band: neither the Act nor the reglugerð sets a weight, a purity or a number of doses that moves an offence from one tier to another, and article 173a turns instead on supplying narcotics to many people, on handing them over for substantial payment, or on doing so in another particularly culpable way, its second paragraph extending the same ceiling to production, preparation, import, export, purchase, delivery, receipt and possession carried out for that purpose. The fine is separate again: 5. gr. of lög nr. 65/1974 sets a fine as the alternative to imprisonment for the base offence, the same article makes the substances, the proceeds of unlawful sale and the articles used forfeit to the Treasury, and it directs increased punishment for a repeat offence involving import or distribution. The 12 year ceiling is not the original figure: 1. gr. of lög nr. 32/2001 raised the aggravated ceiling from 10 to 12 years at article 173a of the General Penal Code, where 10 years had stood since lög nr. 64/1974, and that Act prints the substitution as "kemur: 12 árum". Possession is unlawful and consumption is not among the conduct the two instruments enumerate. 2. gr. of lög nr. 65/1974 and 2. gr. of the reglugerð, headed "Bannákvæði", both list import, export, sale, purchase, exchange, delivery, receipt, production, preparation and possession, and neither of them prints consumption in that list. Iceland has not decriminalised possession. What it has done instead is 2. gr. a of the Act, inserted by lög nr. 48/2020 and amended by lög nr. 41/2025, which lets the Directorate of Health licence a "neyslurými", a supervised consumption room governed by reglugerð nr. 170/2021, in which a user may hold the quantity he intends to consume there. Those figures are not recited here as general background: they describe the offences that this row's placement brings into play. The list read for this cell is Fylgiskjal I of reglugerð nr. 233/2001, read at api.reglugerd.is on 22 September 2026 in the consolidation the publisher serves as current, which carries amendments 1 to 19 and its own last amendment date of 9 August 2025 from reglugerð nr. 879/2025. That consolidation is one amendment behind the law and this cell says so: the 20th amendment, reglugerð nr. 1036/2025, is flagged pending by the publisher although its own 3. gr. commences it on 1 November 2025, and the two texts of 5. gr. visibly differ, the served one opening at pharmacy stock sent to Lyfjastofnun and the amending one opening at the holder of a pharmacy, wholesale or manufacturing licence. It was read in full and it rewrites 5. gr. and the heading of 7. gr. and nothing else, leaving both Fylgiskjöl untouched and printing no transitory article. The Act and the penal code were read in the Lagasafn consolidation stamped "Íslensk lög 1. september 2026", útgáfa 157c, whose own note records that lög nr. 85/2026 will amend the Act from 1 January 2027; that Act was read and its 51. gr. only renames the authority in 2. gr. b. A scan of the 360 regulations the publisher issued between 27 November 2025 and 7 September 2026 found no further amendment, so this cell does not rule out a later change to the list.
If prescribed / medical: This row sits inside the 2. gr. prohibition, so a lawful medical route exists only through one of the exceptions that article prints, an Icelandic marketing authorisation being the ordinary one, and the traveller rule then applies on top of it. Iceland puts the traveller rule in reglugerð nr. 1277/2022 um innflutning einstaklinga á lyfjum til eigin nota, and its 5. gr. governs every medicine that contains, even in part, a substance printed in Fylgiskjal I of reglugerð nr. 233/2001, which is where this row sits. A traveller with no registered domicile in Iceland may carry 30 days at the defined daily dose. A person whose registered domicile is in Iceland may carry 30 days if the medicine was obtained in Iceland and can produce documents showing that, but only 7 days at the defined daily dose if it was obtained abroad, extended to 30 days by a declaration from a doctor holding a valid Icelandic licence stating that the medicine is medically necessary. A traveller moving within the Schengen area may instead present a certificate issued or confirmed by the competent authority of the country of residence under article 75 of the Schengen Convention, and such a certificate is valid for at most 30 days from its issue. Narcotic medicines may not be sent to Iceland by post or by freight at all, and where an import falls outside these permissions 5. gr. routes it back to lög nr. 65/1974. Lyfjastofnun may exempt under 7. gr. but for a medicine under 5. gr. that exemption has to be in hand before the traveller arrives.
Documentation: Customs must be shown a doctor's certificate or the prescription together with its directions for use, or the dispensing label, proving both that the medicine was lawfully obtained and that the quantity carried is necessary, and 3. gr. of reglugerð nr. 1277/2022 lets customs seek an opinion from a public body or a health professional where it suspects the document is wrong or forged. Because this row sits inside the 2. gr. prohibition, the paperwork is doing more work than usual: it is what shows the medicine falls within one of the exceptions in that article rather than inside the ban, so carry it in the dispensed packaging with the label intact and the prescription or a doctor's declaration with it. Where Lyfjastofnun's permission under 7. gr. of reglugerð nr. 1277/2022 is needed, it has to be obtained before travelling rather than at the border, and nothing may be sent ahead by post or freight.

Zolpidem in Iceland, full detail →

Drug laws and enforcement change and vary by country. This is not legal advice. Always confirm with the destination’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.

Before you travel

Verify current rules with the destination country’s official drug authority and your own country’s embassy before traveling. Find the destination’s U.S. embassy & official country guidance →
Non-U.S. travelers: check your own government’s travel advisory and embassy.

If you’re detained or arrested abroad

Contact your own country’s embassy or consulate in the destination immediately, not the destination’s authorities. U.S. citizens: contact the nearest U.S. embassy/consulate and the U.S. State Department at +1-202-501-4444 (from abroad). If a U.S. citizen is arrested or detained abroad →

← All countries Drug index